24

Jun2015

Private Payer PLA Survey

PDCI & H3 Survey on Private Payer Product Listing Agreements Interest, Experience & Expectations Private payers – the community of insurers, Pharmacy Benefit Managers (PBMs) and employers in Canada – are starting to build internal competencies aimed at negotiating product listing agreements (PLAs) with pharmaceutical companies. For the past several years, private ... Read More

23

Jun2015

Australia’s Pharmaceutical Benefits Advisory Committee Recommends Substitution of Biosimilars

Currently in Canada, switching and substitutability between originator biologics and biosimilars has not been established, however that is not the case internationally. Earlier this year the Dutch Medicines Evaluation Board (MEB) supported switching patients from an innovator biologic to a biosimilar, so long as health professionals are involved and the ... Read More

12

Jun2015

QUÉBEC – INESSS Submission Deadlines: 2015-2016

The Minister of Health and Social Services has authorized three updates to the List of Medications covered by the basic prescription drug insurance plan and the List of Medications – Institutions in 2016: February 1, June 1 and October 3, 2016. Updates to the lists of medications for multisource generic ... Read More

19

May2015

PDCI International Trends Series Part 3

PDCI Market Access’s International Trends Series provides the results of an online survey conducted by PDCI between March 19, 2015 and March 25, 2015. Participants were payer and industry stakeholders in both Europe and Canada.  The current issue presents the perspectives of both private and public payers, and industry representatives ... Read More

14

May2015

PDCI International Trends Series Part 2

PDCI Market Access recently launched the International Trends Series, which provides the results of an online survey PDCI conducted between March 19, 2015 and March 25, 2015. Participants were stakeholders in Europe and Canada.  The first issue, “Delisting of Oncology Treatments” was released last week. This current issue reveals the ... Read More

04

May2015

PDCI International Trends Series

In preparation for the recent Pharma Symposium conference held in Toronto on March 31-April 1, PDCI conducted an online survey of a select group of pharmaceutical stakeholders in Canada and Europe.  The purpose of this survey was to gauge whether some of the cost containment mechanisms being implemented in certain ... Read More

25

Mar2015

PDCI Canadian Drug Claims Database FREE TRIAL now available!

PDCI is now offering a FREE TRIAL of its Canadian Drug Claims Database. For those who are interested in the database and would like to learn more, this free trial gives registrants the opportunity to explore the database and test out its functionality at no cost! For more information and to register, please ... Read More

02

Mar2015

‘Successful CDR, pCODR & INESSS Submissions’ Workshop CANCELLED

PDCI's pre-conference workshop at the upcoming Canadian Institute: Pharma Symposium Canada 2015 has been cancelled. For those who may still be interested in the workshop, PDCI is more than happy to provide the workshop in the form of a Webinar or in-house training. Please contact Andrew Brooke for more information on ... Read More

09

Feb2015

Interview with pCPA on the Guidelines for Negotiations

PDCI Market Access Inc. interviewed a representative from one of the pan-Canadian Pharmaceutical Alliance (pCPA) lead provinces and has produced an article providing guidance for negotiating with the pCPA. The pCPA has completed approximately 50 negotiations since it was established in 2010, but stakeholders are still looking for greater transparency ... Read More